Feline panleukopenia (FPL), caused by feline parvovirus, is one of the most severe infectious diseases of cats. Highly contagious and often fatal in unvaccinated animals, it remains a significant welfare concern in feral colonies, rescue centres, and unvaccinated domestic populations.
Feline parvovirus attacks rapidly dividing cells, particularly the intestinal crypt epithelium and bone marrow precursors. Intestinal destruction causes profound gastroenteritis — haemorrhagic diarrhoea, vomiting, anorexia, and dehydration. Bone marrow suppression causes panleukopenia (severe reduction in all white blood cell lines), profoundly impairing immune function. Infection of pregnant queens causes cerebellar hypoplasia in kittens (damage to the developing cerebellum) if the queen is infected during mid-gestation.
Acute FPL causes sudden severe illness: pyrexia, profound depression, vomiting, and haemorrhagic diarrhoea. Young kittens may die peracutely before diarrhoea develops. Severely affected cats can die within 24–48 hours. Survivors of acute disease often suffer extended debilitation during recovery. Case fatality rates in unvaccinated animals can exceed 90% in severe outbreaks. The suffering associated with severe FPL — haemorrhagic enteritis, septicaemia, pain, and multi-organ failure — is extreme.
Feline parvovirus is extremely environmentally stable — it resists many common disinfectants and can persist in the environment for over a year. Transmission is through direct contact with infected cats or their secretions, and through contaminated fomites (bedding, feeding bowls, clothing). The virus can be carried on hands, shoes, and clothing into uncontaminated environments. This environmental stability makes it particularly devastating in multi-cat environments such as rescue centres and boarding catteries.
Vaccination against FPL is highly effective and forms part of the core feline vaccine alongside FHV-1 and FCV. Two or three kitten vaccines starting from 8–9 weeks, followed by a booster at 12 months, and then triennial adult boosters provide durable protection in most cats. Maternal antibody interference means that kittens from vaccinated queens may need a final vaccine at 16 weeks for full protection. The combination of high vaccine efficacy and environmental viral persistence makes vaccination compliance critical — even indoor cats should be vaccinated.
FPL outbreaks in rescue centres and shelters are catastrophic. When suspected, immediate isolation of affected animals, enhanced barrier precautions for staff and volunteers, thorough environmental decontamination with parvocidal disinfectants (sodium hypochlorite at 1:32 dilution), and suspension of cat intake are essential. Vaccination of unaffected cats is immediately protective for those already immunised by previous vaccines. All kittens under 16 weeks should be considered highly vulnerable regardless of vaccine history.
Supportive care is the mainstay of FPL treatment: intravenous fluids and electrolytes to address dehydration, antiemetics, broad-spectrum antibiotics to prevent opportunistic sepsis from compromised gut barriers, nutritional support, and careful monitoring. Intensive care can achieve survival rates of 50–75% in optimally treated cats. Treatment is resource-intensive and expensive — prevention through vaccination is dramatically more cost-effective and welfare-sparing than treatment.
← Back to Animal Welfare Hub